Versanis Bio snags $70M for a ditched Novartis muscle drug, with a little help from its old ...

Retrieved on: 2021-08-31 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Versanis Bio snags $70M for a ditched Novartis muscle drug, with a little help from its old .... View article details on hiswai:

Excerpt

Atlas Venture and Medicxi co-led the series A with participation from Aditum Bio. Read more on. obesity Novartis Atlas Venture venture capital ...

Article found on: www.fiercebiotech.com